“…The conditions were improved by using our previous studies (Kovalovs et al, 2013;Novosjolova et al, 2013). For the biological activity of purine nucleosides, their anticancer and antiviral activity and use as agonists and antagonists of adenosine receptors, see: Lech-Maranda et al (2006); Robak et al (2009); Gumina et al (2003); Fredholm et al (2011); Elzein & Zablocki (2008). For the structure of another 2,6-dichloropurine ribonucleoside, 9-(2 0 -deoxy-3 0 ,5 0 -di-O-4-methoxybenzoyl--d-ribofuranosyl)-2,6-dichloro-9H-purine, see: Yang et al (2012).…”